Mark Schoenberg
2018
In 2018, Mark Schoenberg earned a total compensation of $300K as Chief Medical Officer at UroGen Pharma Ltd., a 72% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $100,000 |
|---|---|
| Salary | $200,000 |
| Total | $300,000 |
Schoenberg received $200K in salary, accounting for 67% of the total pay in 2018.
Schoenberg also received $100K in non-equity incentive plan.
Rankings
In 2018, Mark Schoenberg's compensation ranked 13,166th out of 14,244 executives tracked by ExecPay. In other words, Schoenberg earned more than 7.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,166 out of 14,244 | 8th |
Division Manufacturing | 5,341 out of 5,765 | 7th |
Major group Chemicals And Allied Products | 2,001 out of 2,128 | 6th |
Industry group Drugs | 1,716 out of 1,817 | 6th |
Industry Pharmaceutical Preparations | 1,310 out of 1,391 | 6th |
Source: SEC filing on April 26, 2019.
Schoenberg's colleagues
We found six more compensation records of executives who worked with Mark Schoenberg at UroGen Pharma Ltd. in 2018.
2018
Ron Bentsur
UroGen Pharma Ltd.
Chief Executive Officer
2018
Stephen Mullennix
UroGen Pharma Ltd.
Chief Financial Officer
2018
Gil Hakim
UroGen Pharma Ltd.
Former President
2018
Gary Titus
UroGen Pharma Ltd.
Chief Financial Officer
2018
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2018
Peter Pfreundschuh
UroGen Pharma Ltd.